secwatch.observer — SEC 8-K summary
======================================

Issuer:     REGENXBIO Inc. (RGNX)
CIK:        0001590877
Form:       8-K
Filed at:   2026-10-16T11:00:14+00:00
Accession:  0001193125-26-423376
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4.1-flash:cloud@v2

REGENXBIO director Kenneth T. Mills resigns effective Oct 21; George Migausky named Chairman
--------------------------------------------------------------------------------

- Kenneth T. Mills resigned from REGENXBIO's board on October 14, 2026, effective October 21, 2026, after becoming chief executive officer of another company.
- The company said Mills' decision was not related to any disagreement with REGENXBIO on matters of operations, policies, or practices.
- The board appointed George Migausky as Chairman of the Board in connection with Mills' departure.
- Daniel Tassé stepped down as Lead Independent Director because the new Chairman is an independent director, but remains a member of the board.
- Filing signed October 16, 2026 by Patrick J. Christmas II, Executive Vice President, Chief Strategy & Legal Officer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1590877/000119312526423376/0001193125-26-423376-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1590877/000119312526423376/rgnx-20261014.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-423376

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer